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ABSTRACT
We performed autopsies on two cases of COVID-19. The microcirculations of all organs were the site of the pathological 
findings. Thrombotic microangiopathy was found in the brain and also the kidneys. Vasculitis was also a feature of the 
autopsy findings, together with portal triaditis of the liver. The major pathological findings in both cases were fibrin 
deposits. Within the lung, the fibrin deposits were observed in the alveolar microcirculation in sub-endothelial locations of 
capillaries, arterioles, post capillary venules, and the adventitia of larger vessels. These fibrin deposits in the lungs occurred 
at the sites where pericytes are located in these vessels. The pericyte with its high concentration of ACE-2 receptors and 
its procoagulant state may represent one of the primary sites of action of SARS-CoV-2. A review of pericytes in health 
and disease is undertaken. COVID-19 is a disease of the microcirculation. 
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INTRODUCTION
COVID-19 has affected the lives of everyone 
socially, economically or medically. At the time of 
writing, there has been thirty-eight million confirmed 
cases with over one million and eighty-five thousand 
deaths from COVID-19 globally.1 The pandemic 
continues unabated. SARS-CoV-2 the virus of the 
COVID-19 pandemic is attracted to ACE-2 receptor 
sites causing an endotheliopathy2 with the lungs 
having the main pathological findings.3 Dysfunction 
of the microcirculation4 occurs which leads to hypoxic 
injuries of tissues and organs throughout the body, 
causing morbidity and mortality in the elderly and 
those with co-morbidities such as diabetes mellitus, 
hypertension, chronic lung diseases, and the multi-
system inflammatory syndrome in infants and young 
adults.5
Treatment is mainly preventative and symptomatic. 
Wearing a mask, washing of the hands and social 
distancing are the defense mechanisms used to 
prevent the spread of this respiratory virus. Immune 
therapy, antiviral drugs and ventilator assistance 
have been used in the fight against COVID-19, with 
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measured success.6,7 A vaccine against SARS-CoV-2 is 
forthcoming.
Understanding the pathophysiology of COVID-19 
is most important in designing therapy. A closer look 
at the structure and function of the microcirculation 
with focus on the endothelial cells, and more so the 
pericyte, sheds insights into the secrets of COVID-19.
CASE REPORTS
The autopsies were done under the guidelines 
of the Ministry of Health in the Republic of Trinidad 
and Tobago. Tissues for examination were processed 
and stained with H&E and CD31 (endothelial marker). 
Nasopharyngeal swabs for Covid-19 in both cases were 
processed using Abbott Real-time SARS-CoV-2 assay 
polymerase chain reaction (PCR) with homogenous 
real-time fluorescent detection. Reference weights for 
organs stated in brackets were taken from Autopsy 




A 16-year-old male collapsed shortly after having 
refreshments and was taken to the Accident and 
Emergency department of the General Hospital, where 
cardiopulmonary resuscitation was instituted, but 
he died in spite of resuscitative attempts. He had no 
known medical condition or psychosocial problems. He 
attended secondary school, but because of the COVID-
19 pandemic was tutoured at home via online video 
conferencing like all Secondary and Primary school 
children on the island. Neither he nor his family had 
been in contact with persons suffering with COVID-19.
An autopsy was compulsory.
Autopsy presentation
The body was that of a well-nourished young 
male, 155 cm long, asthenic and of appearance 
consistent with the stated age. Lividity was on the back.
He had pink mucous membranes, was anicteric, 
and cyanosed at the nail beds. There was no edema, 
clubbing, lymphadenopathy, or abnormality of the skin 
and the musculoskeletal system.
The cranium was grossly unremarkable and also 
was the sagittal sinus. There were no extradural or 
subdural hematomas. There was vascular congestion 
of the meninges, and the vessels of the circle of Willis 
were structurally unremarkable. The brain weighed 
1300 g (1440+/-30 g), was edematous and there was 
no other gross pathology of the brain even upon serial 
sectioning.
There were 30 mL of serous pericardial effusion. 
The coronaries were patent and originated from 
their respective ostia, and had no gross pathology. 
There was no thrombus of the atria. The heart 
valves circumferences were as follows: Mitral 9 cm 
(7.8+/-0.7 cm), Aortic 6.5 cm, (5.3+/- 0.4 cm), Tricuspid 
10 cm, (9.9+/-0.9 cm) Pulmonary 5.4 cm (5.6+/-0.5cm). 
The left ventricle thickness was 1.0 cm, and the right 
ventricle 0.2 cm. There was no myocardial injury, 
present or remote. There was cardiomegaly 270 g 
(RR; 125-250 g).
T h e  p u l m o n a r y  a r t e r i e s  c o n t a i n e d  n o 
thromboembolism. There were approximately 350 mL 
of serosanguinous pleural effusions in each pleural 
cavity. The larynx was structurally unremarkable, 
and there was hyperemia of the trachea. There was 
no foreign body within the tracheobronchial tree or 
tumor. The right lung weighed 770 g (455 g upper limit 
of normal), and the left lung 710 g (415 g upper limit 
of normal) and were markedly congested, edematous, 
and contained no area of consolidation.
There were no bite marks of the tongue; no 
chemical burns of the oropharynx, or esophagus. The 
stomach contained a clear, non-pungent fluid and there 
was no gastritis. The duodenum and the rest of the 
gastrointestinal tract were structurally unremarkable. 
There was free flow of bile. The liver weighed 1950 g 
(1523 g upper limit of normal), and had a focal area 
of sub-capsular hemorrhage, attributable to an injury 
obtained during resuscitative attempts. The rest of 
the liver was congested. The spleen weighed 200 g 
(RR; 150-200 g), was congested, and revealed no 
abnormality upon serial sectioning.
The kidneys each weighed 90 g (RR; right kidney 
90-110 g, left kidney 98-112 g), had smooth cortical 
surfaces, and normal cortico-medullary junctions. The 
adrenals combined weight was 20 g (RR; 16-20 g), 
and were grossly unremarkable. The ureters and the 
urinary bladder were structurally unremarkable, with 
the latter containing 50 mL of amber-coloured urine.
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The genitals were structurally unremarkable.
Nasopharyngeal swab testing for COVID 19 using 
PCR, performed after autopsy was positive.
Histology
Heart: There was idiopathic cardiomegaly with 
enlarged myocyte nuclei, some showing bizarre forms 
(Figure 1A).
B r a i n :  T h e  b r a i n  s h o w e d  t h r o m b o t i c 
microangiopathy (Figure 1B). In addition, medium sized 
vessels were thrombosed and showed a vasculitis with 
a moderate infiltrate of lymphocytes in the immediate 
perivascular region.
Lung: There was hyaline membrane, pulmonary 
edema, pulmonary hemorrhage and areas of interstitial 
pneumonia. Fibrin microthrombi were evident within 
alveoli capillaries, arterioles, and post capillary 
venules. In many areas, the fibrin thrombi were within 
the wall of capillaries, arterioles and venules in the 
sub-endothelial locations, but not within the lumen 
of these vessels (Figure 1C and 1D). Fibrin deposits 
were also observed in the adventitia of the large 
pulmonary vessels. These sites of fibrin deposition 
correspond with the locations of the pericytes in the 
vascular system.
Liver: There was a moderate infi ltrate of 
lymphocytes within the portal triad (Figure 2).
This COVID-19 case showed both the inflammatory 
and thrombotic responses to COVID-19 occurring in 
the lung and brain. This young male had idiopathic 
cardiomegaly and died in congestive cardiac failure, 
with superimposed COVID-19.
Figure 1. Photomicrographs of: A – Cardiomyocyte showing enlarged nucleus (arrow) (H&E x 400); B – Brain 
showing thrombotic microangiopathy (arrows) (H&E x 400); C – Alveolar-capillary section showing subendothelial 
fibrin deposits (arrows) lumen represented as L (H&E x 200); D – Pulmonary section showing unstained subendothelial 
fibrin deposits (F), brown-stained endothelial cells (arrow) with lumen free of thrombus (L) (CD31 stain x 400).
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CASE 2
Case history
The deceased was an 84-year-old male with urinary 
retention due to benign prostatic hyperplasia and was 
managed with an indwelling Foley catheter. He had 
no other known medical illnesses. He was discovered 
dead at home in his bathroom. His family indicated that 
he was clinically well prior to his death. There was no 
history of diabetes mellitus, hypertension, recent travel, 
exposure to infectious persons, toxic agents, or any 
history of tobacco smoking or alcohol use. He dwelled 
in his home with his elderly wife and grandchildren.
A partial autopsy was performed.
Autopsy presentation
The body was that of a well-preserved, elderly 
male, cyanosed at the nail beds, and with no external 
marks of violence or trauma. The mucous membranes 
were pale. A urinary catheter was in-situ.
The trachea and lower airways were hyperemic. 
There was no tumor or foreign bodies in the 
tracheobronchial tree. There were 50 mL and 30 mL 
of serous effusions in the right and left pleural cavities 
respectively. The left lung weighed 750 g (RR; 325-480 g) 
and the right lung, 860 g (RR; 360-570 g). They were 
congested and edematous. There was no hilar 
lymphadenopathy. There were areas of consolidation 
at the bases of all lobes of the right and left lungs. 
There was no evidence of pulmonary embolism.
The heart weighed 310 g (RR; 270-360 g). The 
valve circumferences and ventricular thicknesses were 
within normal limits.
The coronary arteries showed mild atherosclerotic 
disease with approximately 20% stenosis of the left 
anterior descending, circumflex and right coronary arteries.
The myocardium revealed no recent or old injuries.
The liver weighed 1100 g (RR; 1500-1800 g) and 
spleen 150 g (RR; 90+/-40 g), both appeared congested 
with no other macroscopic evidence of abnormality.
Figure 2. Photomicrograph of the liver showing portal triaditis (H&E x 200).
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Both kidneys weighed 130 g respectively (RR; 313 g 
combined weight) and showed an ill definition of the 
cortico-medullary junctions and chronic pyelonephritis. 
The prostate was enlarged, with a prominent middle 
lobe, and the urinary bladder contained cloudy urine.
There was no injury to the scalp or the underlying 
skull bones. The brain was not examined.
COVID-19 Test on nasopharyngeal swab, done at 
autopsy using PCR was positive.
Histology
Lungs: This showed interstitial pneumonia. 
(F igure 3A) F ibr in depos i ts  were d ist r ibuted 
throughout the alveoli microcirculation, within the 
subendothelial locations of capillaries, arterioles, 
venules, and the adventitia of large pulmonary vessels 
(Figure 3B, 3C, 4A, 4B, 4D).
Heart: This showed focal ischemic changes 
globally.
Kidney :  There were microthrombi within 
glomerular tuft and interlobular arteries.
Liver: There was portal triaditis.
This elderly male died from COVID-19 with diffuse 
fibrin deposits within the alveolar microcirculation and 
the adventitia of the larger pulmonary vessels. The 
resultant hypoxia would have contributed to multiple 
organ failure.
DISCUSSION
The microcirculation is the terminal vascular 
network of the systemic circulation consisting of 
arterioles, capillary beds and post capillary venules. In 
this region, oxygen is transferred from red blood cells 
Figure 3. Photomicrographs of the lung. A – Pulmonary section showing interstitial pneumonia (H&E, x 400); 
B – Pulmonary section showing fibrin deposit (arrow) within the wall of a venule (H&E, x 400); C – Pulmonary section 
showing subendothelial deposit in a capillary (arrow) (H&E, x 400); D – Pulmonary section showing fibrin deposit in 
subendothelial location and subsequent destruction of the capillary wall (arrow) (H&E, x 400).
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to tissues and organs. This facilitates respiration at 
the cellular and tissue level. Hypoxic injury occurs to 
tissues and organs if the oxygen delivery is interrupted 
in these micro-vessels. In COVID-19, interruption of 
oxygen delivery to tissues and organs occurs as a result 
of fibrin deposition within the microcirculation, thereby 
exerting its pathological effects.9
The pulmonary microcirculation resides within 
the alveolus. Here, the alveolar-capillary endothelial 
cells, contribute to and share a common basement 
membrane with type I and type II epithelial cells. The 
type I epithelial cells pave the alveolus, and is the site 
of gas exchange. In contrast, type II epithelial cells 
manufacture surfactant, reducing the surface tension 
within the alveolus to allow respiration at atmospheric 
pressure. They also divide to produce the type I cells.
Cross-talks between epithelial and endothelial 
cells occur therefore injury to epithelial cells can 
result in injury to endothelial cells. SARS-CoV-2 is a 
respiratory virus, which initially affects the respiratory 
tract but causes its major pathological effects in the 
alveolar microcirculation.3
The intima of the capillary is composed of a 
single layer of endothelial cells resting on a basement 
membrane. This forms the skeleton of the capillaries. 
Hidden on the abluminal side of the endothelial cell is 
the pericyte, with a complex network of matrix; which 
adheres to and encircles the luminal endothelial cell 
through peg-and-socket junctions, gap junctions, and 
adhesion plaques; and is embedded in the basement 
membrane. The matrix contains micro-particles, which 
are secreted by the pericytes themselves by exocytosis. 
The gap junctions allow the pericytes to communicate 
with the endothelial cells by exchanging of ions and 
small molecules. The peg-and-socket contacts enable 
pericytes to penetrate through the basal lamina and 
Figure 4. Photomicrographs of the lung. A – Pulmonary arteriole showing fibrin deposit in the adventitia (arrow) 
(H&E x 400); B – Pulmonary artery showing fibrin deposit underlying endothelial layer (arrow) (H&E x 400); 
C – Detached thrombus (arrow) in pulmonary vein (H&E x 400); D – Pulmonary post-capillary venule showing fibrin 
deposit underlying endothelial layer (arrow) (H&E x 400).
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make contact with other cells and nearby vessels.10-12 
One pericyte with its complex finger-like matrix can 
make contact with multiple endothelial cells. The 
pericyte contributes to the basement membrane, which 
is shared with the endothelial cell.
Pericytes are a heterogeneous population of cells. 
There are three categories of pericytes; ensheathing 
pericytes, which are found on precapillary arterioles; 
mesh pericytes; and thin stranded pericytes.11,13,14 
These pericytes are found in the abluminal regions of 
the intima in arterioles, venules, capillaries, and in the 
adventitia of larger vessels.15
Pericytes play different roles in the microvasculature 
stability, barrier function and perfusion. They are 
involved in the preservation of vascular rheology and 
homeostasis, including regulation of blood flow, 
angiogenesis, structural stabilization of the vasculature, 
and vascular permeability.16-18
The endothelial cells, the abluminal pericyte and 
the basement membrane, are collectively called the 
endothelium, and any injury/dysfunction of this unit is 
often referred to as endotheliopathy. The endothelium 
has important roles in homeostasis, maintaining the 
balance between prothrombotic and antithrombotic 
states. The endothelial cells express thrombomodulin, 
which has anticoagulant properties keeping the blood 
in a fluid state. On the other hand, the pericytes are 
procoagulant19 and have a high concentration of Tissue 
Factor (TF), which is expressed within its cytoplasm, and 
as microparticles in its matrix/basement membrane.
In health, minor injuries to the microcirculation 
cause plasma to leak through gap junctions interacting 
with TF of the pericytes. Microthrombosis takes places 
as a result of the interaction. This microthrombotic 
event is an innate immune response to microvascular 
injury, which is intended to restore the integrity of 
the microcirculation. Hemostasis takes place with 
thrombomodulin, and fibrinolytic modulation in 
physiological states. However, pathological thrombosis 
of the microcirculation occurs in COVID-19,19 not only 
because of passive plasma flow and interaction with 
subluminal pericytes, but in addition, to adhesion of 
SARS-CoV-2 virus to ACE-2 receptor sites, thereby 
causing cytopathic effects on pericytes.
Other factors play a role in homeostasis. The 
major prothrombotic factors are TF; von Willebrand 
factor; protease-activated receptor; Thromboxane A2; 
von Willebrand platelet activating factor; plasminogen 
activator inhibitor-1; and adhesive molecules such as 
P-selectin, E-selectin, platelet adhesion molecule-1, 
and vascular cell adhesion molecule-1. These factors 
are counteracted by anticoagulants such as protein C, 
tissue factor inhibitor, thrombomodulin, heparin, nitric 
oxide synthase, profibrinolytic factors, anti-platelet 
factors, prostacyclin, and type 1 motif (ADAMTS13).20,21 
Hence, there are a complex and heterogeneous 
admixture of plasma and cellular constituents that play 
an active role in homeostasis. The interplay amongst 
blood flow, the compositions of blood and vessel wall 
components are necessary to understand the operant 
pathophysiology of thrombotic and bleeding disorder 
and the maintenance of homeostasis.21
In sepsis and ischemia, inflammatory mediators 
are released from platelets and other inflammatory cells 
causing injury to the microcirculation. The endothelial 
cells contract and widen gap junctions, rendering the 
pericytes to mediate the leucocytes diapedesis through 
these gaps and endothelial cell junctions. Pericyte gap 
enlargement occurs under these conditions facilitating 
the flow of plasma and recruitment of more leucocytes 
in the injured region.17,22-24 Macrophage migration 
inhibition factor produced by macrophages, and 
released in the alveolar space, also plays a central role 
in the transmigration of neutrophils at sites of injury 
in the microcirculation.
Pericytes control the microvascular modeling 
and proliferative state of the endothelium and base 
membrane in angiogenesis.17,25-27
Notwithstanding the foregoing, the pericytes 
have been an overlooked player in the pathobiology 
of the disease. In fact, they play a central role in 
the micro-thrombosis, diapedesis of leucocytes, and 
angiogenesis after the injury to the microcirculation. 
All these properties of pericytes are manifested in 
COVID-19 disease.
ACE-2 receptor sites are the targets for the SARS-
CoV-2 virus. These receptor sites are located on nasal 
and oral mucosae, nasopharyngeal cells, enterocytes, 
type I and type II epithelial cells in the alveolus, and 
endothelial cells in the microcirculation.28 Pericytes also 
contain high concentrations of ACE-2 receptor sites.29
In the two cases in discussion, one died suddenly 
and the other was found dead at his residence. Neither 
had ventilator assistance nor was on pharmaceutical 
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therapy. Hence, the pathologic findings seen in these 
two cases were as a direct result of SARS-CoV-2 
infection and its cytopathic effects on the endothelial 
cell, the subluminal pericyte and its basement 
membrane.
The teenage patient died from a combination 
cerebral thrombosis, thrombotic microangiopathy 
and vasculitis. These pathological events have been 
described in COVID-19 patients.30,31 He also had 
idiopathic cardiomegaly, which was discovered at 
autopsy. Congestive cardiac failure also contributed 
to his demise. Heart failure is a noted complication in 
COVID-19.32 It is interesting to note that cardiomyocyte 
expression of ACE-2 receptor sites are low, but the 
highest expression of ACE-2 receptor sites are in 
cardiac pericytes,33,34 which may represent the target 
cardiac cells in SARS-CoV-2 infection. The pericytes’ 
injury due to SARS-CoV-2 cytopathic effect may result 
in capillary endothelial cells dysfunction, inducing 
microvascular dysfunction. Therefore, heart disease 
patients, if infected by the SARS-CoV-2, may have a 
higher risk of myocardial injury, cardiac arrhythmias, 
heart failure, and critically ill conditions.32,34,35
A moderate portal triaditis was also a feature 
seen in this patient. This might represent part of the 
inflammatory response that occurs to SARS-CoV-2 
infecting pericytes in vessels in the portal tract. The 
portal triaditis might be responsible for the abnormal 
liver function seen in COVID-19.36
It was within the lung that major pathological 
changes were observed. Fibrin was deposited in the 
sub-endothelial locations of the microcirculation 
in alveolar capillaries, venules and arterioles and 
in the adventitia of larger vessels. Disruption of 
the microvasculature walls in the alveolus by fibrin 
deposits led to extension of fibrin within alveolar 
spaces (Figure 3D) and vessel lumen (Figure 4C). The 
sites within the microcirculation, where fibrin deposits 
occurred, are the locations of the pericytes. With this 
understanding, we concluded that the pericyte with its 
high concentration of ACE-2 receptor sites, the target 
for SARS-CoV-2, and its procoagulant state, is at the 
center of the vascular coagulopathy seen in the lung. 
Although the alveolar epithelial cells contain ACE-2 
receptor sites, epithelial cell proliferation was not 
as marked as was seen in H1N1 flu. However, there 
was patchy interstitial pneumonia. COVID-19 seems 
predominantly to be affecting the microcirculation, 
with fibrin deposit being the pathological feature.19 
This disruption and destruction of the microcirculation 
by fibrin deposits and its extension into the alveolar 
spaces causes decreased oxygen exchange, resultant 
hypoxia and respiratory failure. Inflammatory mediators 
released during this hypoxic state gain entrance to the 
systemic circulation, thereby initiating the multiple 
organ dysfunction syndrome.20,37
Ackerman et al.38 described pulmonary vascular 
endothelialitis, thrombosis and angiogenesis in 
COVID-19. These pathological findings are all caused 
by the vascular pericytes.17,22,23,27,39 They also reported 
that endothelial cells in the specimens from patients 
with COVID-19 showed “disruption of intercellular 
junctions, cell swelling, and a loss of contact with the 
basal membrane”. These latter findings would certainly 
involve pericytes through the disrupted intercellular 
junctions. Although the pathobiology of the pericytes 
was recognized in their report, the pericytes was 
omitted from the discussion.
Frantzeskakil et al.40 in their article entitled 
“Immunothrombosis in Acute Respiratory Distress 
syndrome: Crosstalk between inflammation and 
coagulation”, recognized the Imbalance between 
coagulation and inflammation as a predominant 
characteristic of ARDS, leading to extreme inflammatory 
response and “diffuse fibrin deposition in vascular 
capillary bed and alveoli”. They also attributed TF 
production to the vascular endothelium. They did not 
recognize that the inflammation, the fibrin deposits in 
the capillary bed, and alveolar spaces in ARDS were 
all part of the pathobiology of the pericytes. Both 
Ackerman et al.38 and Frantzeskaki et al.40 overlooked 
the role of pericytes in the pathobiology of the 
microcirculation.
COVID-19 i s  a  d i sease  that  a f fec t s  the 
microcirculation3,41,42 with the pericytes playing a 
central role in the pathobiology of the disease process. 
The pericytes with its procoagulant state, its expression 
of TF, and its high concentration of ACE-2 receptor 
sites are the target cells for SARS-CoV-2 infection.33 
The cytopathic effect of SARS-CoV-2 on endothelial 
cells exposes the abluminal pericytes, through gap 
junctions, to constituents of plasma and the SARS-
CoV-2. The resultant cytopathic effect of SARS-CoV-2 
on exposed pericytes generates the pathology of 
thrombosis, inflammation, and angiogenesis seen in 
COVID-19.
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CONCLUSION
SARS-CoV-2 virus attaches to receptor sites on both 
endothelial cells and pericytes of the microcirculation. 
It is possible that SARS-CoV-2 attachment to ACE-2 
receptor sites on pericytes may be responsible for 
the major pathology seen in COVID-19. The current 
literature and the two autopsy findings support 
the involvement of the pericyte in SARS-CoV-2 
pathogenesis. Further work is required to clarify the 
role of the pericyte in SARS-CoV-2 pathogenesis, if 
COVID-19 is to be efficiently managed.
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